Yahoo · Oct 29, 2026
Establishment Labs Holdings Inc. Q3 2026 Earnings Call Summary
Moby summary of Establishment Labs Holdings Inc.'s Q3 2026 earnings call
NASDAQ · ESTA
Healthcare · Medical - Devices
$69.82
Down-$0.93 (-1.31%)
Updated Nov 17, 2026, 8:16 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ESTA
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 16, 2026
ESTA closed at $69.82 after 21 trading sessions, up 19.84% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | $70.07 | $70.61 | $69.34 | $69.82 | 362.56K |
| Nov 13, 2026 | $68.98 | $71.58 | $67.56 | $70.75 | 367.35K |
| Nov 12, 2026 | $70.47 | $70.78 | $67.73 | $68.62 | 314.97K |
| Nov 11, 2026 | $67.555 | $71.57 | $67.555 | $70.69 | 339.91K |
| Nov 10, 2026 | $67.77 | $69.42 | $66.50 | $67.23 | 391.33K |
| Nov 9, 2026 | $67.94 | $69.92 | $61.83 | $68.52 | 331.16K |
| Nov 6, 2026 | $63.91 | $67.98 | $63.08 | $67.02 | 321.68K |
| Nov 5, 2026 | $66.93 | $66.96 | $61.50 | $64.42 | 464.32K |
| Nov 4, 2026 | $64.41 | $67.295 | $64.41 | $66.94 | 386.8K |
| Nov 3, 2026 | $60.92 | $62.905 | $60.56 | $61.40 | 498.36K |
| Nov 2, 2026 | $63.15 | $63.775 | $60.48 | $61.07 | 708.35K |
| Oct 30, 2026 | $67.38 | $68.335 | $60.25 | $62.46 | 1.03M |
| Oct 29, 2026 | $69.395 | $71.88 | $64.35 | $68.41 | 1.04M |
| Oct 28, 2026 | $65.92 | $70.53 | $65.92 | $68.97 | 790.79K |
| Oct 27, 2026 | $66.64 | $67.4494 | $65.32 | $66.95 | 489.95K |
| Oct 26, 2026 | $63.65 | $67.15 | $63.65 | $65.78 | 578K |
| Oct 23, 2026 | $63.14 | $64.94 | $62.85 | $63.80 | 346.31K |
| Oct 22, 2026 | $62.07 | $65.61 | $61.98 | $63.52 | 762.56K |
| Oct 21, 2026 | $61.50 | $63.40 | $61.08 | $62.28 | 474.8K |
| Oct 20, 2026 | $58.63 | $61.49 | $58.39 | $61.07 | 359.53K |
| Oct 19, 2026 | $60.61 | $60.61 | $57.88 | $58.26 | 349.19K |
The latest Smart Investors Daily articles mentioning ESTA.
Company
Market Activity
Research & News
ESTA research
Company profile and research snapshot.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 29, 2026 | BTIG | Buy | — |
| Oct 26, 2026 | TD Cowen | Buy | — |
| Oct 15, 2026 | TD Cowen | Buy | — |
| Sep 1, 2026 | BTIG | Buy | — |
| Aug 13, 2026 | Citigroup | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 29, 2026
Moby summary of Establishment Labs Holdings Inc.'s Q3 2026 earnings call
Benzinga · Oct 29, 2026
BTIG analyst Sam Eiber maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and lowers the price target from $103 to $93.
Yahoo · Oct 29, 2026
Establishment Labs (NASDAQ:ESTA) reported third-quarter revenue growth of 33.9% year over year to $72 million, driven by U.S. market-share gains and expansion across international markets, while the company generated positive free cash flow for the first time in its history. Chief Executive Officer
Yahoo · Oct 29, 2026
Establishment Labs (ESTA) delivered earnings and revenue surprises of -29.63% and +8.03%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning ESTA.